Institutional members access full text with Ovid®

Using an Intrauterine Device in Immunocompromised Women

Browne, Hyacinth MD1; Manipalviratn, Somjate MD1; Armstrong, Alicia MD, MHSCR1

doi: 10.1097/AOG.0b013e318183464e
Current Commentary

Intrauterine devices (IUDs) are a viable treatment option for immunocompromised women who need contraception or menses suppression. They may also be an alternative treatment for women who have a contraindication to estrogen use. A review of the literature on IUD use in this population is sparse, but currently available data suggest that immunocompromised women are not at greater risk of developing pelvic infections.

Immunocompromised women are not at greater risk of developing pelvic infections when using intrauterine devices.

From the 1Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.

Supported in part by the Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health.

Corresponding author: Hyacinth Browne, MD, Program in Reproductive and Adult Endocrinology, NICHD, CRC 1 East Rm 1-E-3140, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892; e-mail: brownehy@mail.nih.gov.

Financial Disclosure The authors have no potential conflicts of interest to disclose.

© 2008 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.